FP400INFLUENCE OF THE SECONDARY HYPERPARATHYROIDISM IN IRON REQUIREMENTS IN DIALYSIS PATIENTS ON ERYTHROPOIESIS-STIMULATING AGENT THERAPY. A PROSPECTIVE CONTROLLED STUDY | Publicación